Eckert & Ziegler Strahlen- und Medizintechnik AG Logo

Eckert & Ziegler Strahlen- und Medizintechnik AG

ISIN: DE0005659700 | Ticker: EUZ | LEI: 391200EUDABLUKXCKG48
Sector: Health Care – Sub-Industry: Biotechnology
Country: Germany

About Eckert & Ziegler Strahlen- und Medizintechnik AG

Company Description

The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products.
Eckert & Ziegler was founded in 1997 as a holding company.

Year founded

1997

Served area

Worldwide

Headcount

828

Headquarters

Robert-Rössle-Straße 10, 13125 Berlin – Germany

Filings & Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume
30.08.23 Eckert, Dr. Andreas Supervisory board Sell EUR 1,526,400.00
30.08.23 Eckert Wagniskapital und FrΓΌhphasenfinanzierung GmbH Close relation Buy EUR 1,526,400.00
11.08.23 Perschmann, Frank Supervisory board Buy EUR 16,600.00
13.01.23 NEON Equity AG Close relation Buy EUR 2,115.00
12.01.23 Blunck, Dr. Thomas Board Sell EUR 57,402.00
12.01.23 Blunck, Dr. Thomas Board Sell EUR 32,160.00
11.01.23 Bouterfa, Dr. Hakim Board Buy EUR 124,800.00
21.12.22 Eckert Wagniskapital und FrΓΌhphasenfinanzierung GmbH Close relation Buy EUR 1,432,800.00
06.12.22 Maennig, Prof. Dr. Wolfgang Supervisory board Buy EUR 72,745.31
05.12.22 Carpio GmbH Close relation Buy EUR 73,826.53

Capital markets information

ISIN

DE0005659700

LEI

391200EUDABLUKXCKG48

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Designated Sponsor

DZ Bank AG Deutsche Zentral-Genossenschaftsbank

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

SDAX

TecDAX

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.